Company
Team
CORPORATE GOVERNANCE
Platforms
Glycovirology
Degenerative Diseases
pipeline
ProLectin Pipeline
Degenerative Disease pipeline
Resources
IN THE NEWS
Stroke video
faq
SCIENTIFIC PUBLICATIONS
investors
Company presentation
press releases
Reports
financial
Contact US
$BIXT
Company
Platforms
Glycovirology
Degenerative Diseases
Resources
Investors
Pipeline
contact us
Glycovirology Scientific Publications
featured
Galectin approach to lower covid transmission - Drug Development for clinical use
Galectin approach to lower covid transmission - Drug Development for clinical use
Chemokines modulate glycan binding and the immunoregulatory activity of galectins
Chemokines modulate glycan binding and the immunoregulatory activity of galectins
An Oral Galectin Inhibitor in COVID-19—A Phase II Randomized Controlled Trial
An Oral Galectin Inhibitor in COVID-19—A Phase II Randomized Controlled Trial
load more
Gal power: the diverse roles of galectins in regulating viral infections
Gal power: the diverse roles of galectins in regulating viral infections
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
Potential Role of Galectin-glycan Lattices in SARS-CoV-2 Infection and Pathogenesis: A Hypothesis
Potential Role of Galectin-glycan Lattices in SARS-CoV-2 Infection and Pathogenesis: A Hypothesis
Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis
Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis
Previous
load more
go back